Pegilodecakin
- Generic Name
- Pegilodecakin
- Drug Type
- Biotech
- CAS Number
- 1966111-35-2
- Unique Ingredient Identifier
- 5Z9850I25F
- Background
Pegilodecakin is under investigation in clinical trial NCT03382912 (Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath